The Early Outcomes of Nurse Case Management in Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator: A Prospective Randomized Controlled Trial

Table 3

The parameters of time from symptom onset to hospital, time from hospital to received rt-PA, and time from onset to received rt-PA were compared between experimental and control groups.

Sample characteristics	Experimental group (n=38)		Control group (n=38)		t-test
	Number	Percentage ()	Number	Percentage ()
Time from symptom onset to hospital					.994
15 - 30 minutes	2	5.26	2	5.26
31 - 60 minutes	6	15.78	2	5.26
61 – 90 minutes	3	7.89	7	18.42
91 - 120 minutes	6	15.78	11	28.94
121 – 150 minutes	12	31.57	6	15.78
151 – 180 minutes	6	15.78	4	10.52
181 – 210 minutes	3	7.89	4	10.52
Mean standard deviation	=119.29	SD =49.00	=113.00	SD =51.10
Time from hospital to treatment					.001
0 – 30 minutes	1	3.33	16	42.11
31 – 60 minutes	24	63.16	19	50
61 – 90 minutes	11	36.67	2	5.26
91 – 120 minutes	2	5.26	1	2.63
Mean standard deviation	=39.02	SD=0.68	=59.30	SD =0.75
Time from symptom onset to treatment					.013
61 – 90 minutes	2	5.26	2	5.26
91 – 120 minutes	6	15.79	3	7.89
121 – 150 minutes	5	13.16	4	10.53
151 - 180 minutes	14	36.84	13	34.21
181 - 240 minutes	9	23.68	10	26.32
241- 270 minutes	2	5.26	6	15.79
Mean standard deviation	=162.79	SD=16	=179	SD=16.5